1999
Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island
Rich J, Dickinson B, Macalino G, Flanigan T, Towe C, Spaulding A, Vlahov D. Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 161-166. PMID: 10843530, DOI: 10.1097/00126334-199910010-00008.Peer-Reviewed Original ResearchConceptsSelf-reported injection drug useIncidence of HIVInitiation of treatmentInjection drug useCase-control studySeronegative womenRecent temporal trendsHIV testHIV infectionHIV-positiveHIV prevalenceNonwhite raceRisk factorsAnnual prevalenceMandatory HIVHigh riskControl studyDrug useSexual riskHIVWomenPrevalencePrior incarcerationIncidenceIncarcerated womenCompliance With Universal Precautions in Correctional Health Care Facilities
Gershon R, Karkashian C, Vlahov D, Kummer L, Kasting C, Green-McKenzie J, Escamilla-Cejudo J, Kendig N, Swetz A, Martin L. Compliance With Universal Precautions in Correctional Health Care Facilities. Journal Of Occupational And Environmental Medicine 1999, 41: 181-189. PMID: 10091141, DOI: 10.1097/00043764-199903000-00007.Peer-Reviewed Original ResearchConceptsHealth care workersBloodborne exposuresUniversal precautionsCare workersCompliance rateCorrectional health care workersCorrectional health-care facilitiesBody fluid exposuresCross-sectional studyHealth care facilitiesPersonal protective equipmentCorrelates of complianceSharps disposalModifiable correlatesProtective eyewearInterventional strategiesFluid exposureCare facilitiesOverall complianceProtective equipmentCompliance ScaleFace maskAdverse working conditionsDemographic factorsExposure
1994
Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system.
Kendig N, Stough T, Austin P, Kummer L, Swetz A, Vlahov D. Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. Public Health Reports 1994, 109: 756-60. PMID: 7800784, PMCID: PMC1403577.Peer-Reviewed Original ResearchConceptsHIV infectionInfected inmatesHigher CD4 cell countsHuman immunodeficiency virus (HIV) infectionHIV-seropositive inmatesCD4 cell countImmunodeficiency virus infectionAnti-retroviral therapyVoluntary HIV testingPrimary care providersClinical case managementPublic health interventionsState correctional systemCorrectional settingsImmediate medical treatmentClinical profileHIV testingInitial diagnosisVirus infectionCare providersMedical treatmentCell countHealth interventionsCase managementInfection
1992
Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity
Concha M, Graham N, Muñoz A, Vlahov D, Royal W, Updike M, Nance-Sproson T, Seines O, McArthur J. Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity. American Journal Of Epidemiology 1992, 136: 1338-1348. PMID: 1362630, DOI: 10.1093/oxfordjournals.aje.a116446.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsBaltimoreBlack or African AmericanCD4-Positive T-LymphocytesChronic DiseaseCognition DisordersConfounding Factors, EpidemiologicEducational StatusEmploymentEvaluation Studies as TopicFemaleHIV SeropositivityHIV SeroprevalenceHIV-1HumansLeukocyte CountLinear ModelsMaleMass ScreeningNeuropsychological TestsPopulation SurveillancePredictive Value of TestsPrisonsPsychomotor PerformanceSubstance Abuse, IntravenousConceptsNeuropsychological test performanceHIV-1 seropositivityIntravenous drug usersTest performanceNeuropsychological performancePractice effectsHuman immunodeficiency virus type 1 (HIV-1) infectionDrug usersVirus type 1 infectionSubstance abuseSignificant practice effectsHIV-1 serostatusType 1 infectionIntravenous Experience (ALIVE) studyFrequency of drugChronic substance abuseNeuropsychological functioningCognitive performanceImmunodeficiency syndromeAsymptomatic stageHigh prevalenceOutcome measuresDrug useIntoxicated individualsMultivariate analysisHIV-1 infection in the correctional setting.
Vlahov D. HIV-1 infection in the correctional setting. NIDA Research Monograph 1992, 118: 51-61. PMID: 1620226.Peer-Reviewed Original Research
1991
Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilities
1989
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987.
Vlahov D, Brewer F, Muñoz A, Hall D, Taylor E, Polk B. Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1989, 2: 283-90. PMID: 2786071.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Incoming male inmatesHIV-1 seroprevalenceIntravenous drug useType 1 infectionImmune deficiency syndromeCause of deathRisk of infectionVirus type 1Drug use variablesWestern blot techniqueCrude prevalenceRisk factorsUnivariate analysisDeficiency syndromeHIV-1Temporal trendsDrug usersDrug useExcess serumIncoming inmates
1988
Transmission of HIV-1 within a statewide prison system
Brewer T, Vlahov D, Taylor E, Hall D, Munoz A, Polk B. Transmission of HIV-1 within a statewide prison system. AIDS 1988, 2: 363-368. PMID: 3146264, DOI: 10.1097/00002030-198810000-00005.Peer-Reviewed Original Research